Cargando…
供者CD19 CAR-T细胞治疗急性B淋巴细胞白血病移植后复发九例临床观察
OBJECTIVE: To investigate the long term efficacy and side effects of a donor-derived CD19 chimeric antigen receptor（CAR）T-cell（HI19α-4-1BB-ζ CAR-T）therapy in the treatment of patients with relapsed B-cell acute lymphoblastic leukemia（B-ALL）after allogeneic hematopoietic stem cell transplantation（all...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293002/ https://www.ncbi.nlm.nih.gov/pubmed/34218580 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.05.006 |